Endurant Capital Management’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

Endurant Capital Management’s Portfolio PARN Stock Details PARN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-328,781	Closed	-$227K	–	105
2016 Q4	$227K	Sell	328,781 -120,021	-27%	-$143K	0.09%	69
2016 Q3	$637K	Hold	448,802	–	–	0.24%	68
2016 Q2	$732K	Buy	448,802 +62,900	+16%	+$116K	0.24%	65
2016 Q1	$822K	Sell	385,902 -49,725	-11%	-$137K	0.27%	61
2015 Q4	$1.69M	Buy	435,627 +1,761	+0.4%	+$6.7K	0.57%	49
2015 Q3	$1.49M	Buy	433,866 +26,723	+7%	+$113K	0.5%	50
2015 Q2	$2.02M	Buy	407,143 +119,980	+42%	+$529K	0.59%	48
2015 Q1	$1.41M	Buy	287,163 +37,736	+15%	+$174K	0.47%	60
2014 Q4	$1.03M	Buy	+249,427	New	+$1.13M	0.41%	66

Other funds holding PARN

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Endurant Capital Management's PARN Position: Q1 2017 in Review

Endurant Capital Management sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q1 2017, closing a stake of 328,781 shares — an estimated $227K sold.

Endurant Capital Management first reported a position in PARN in Q4 2014 and held it in 9 quarters. The position peaked at $2.02M in Q2 2015. 2 funds tracked by Wall St. Rank hold PARN as of Q1 2017.

Endurant Capital Management reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q1 2017 after selling out during the quarter.
Endurant Capital Management sold 328,781 Parnell Pharmaceuticals Holdings Ltd shares in Q1 2017, an estimated $227K.
Endurant Capital Management first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q4 2014 and held it in 9 quarters.
Endurant Capital Management's Parnell Pharmaceuticals Holdings Ltd position peaked at $2.02M in Q2 2015.
2 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q1 2017.

Based on Endurant Capital Management's 13F filing for Q1 2017, filed 15 May 2017.